Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)

BACKGROUND: Genomic profiling of tumor tissue may aid in identifying predictive or prognostic gene signatures (GS) in some cancers. Retrospective gene expression profiling of melanoma and non-small-cell lung cancer led to the characterization of a GS associated with clinical benefit, including impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Saiag, P., Gutzmer, R., Ascierto, P. A., Maio, M., Grob, J.-J., Murawa, P., Dreno, B., Ross, M., Weber, J., Hauschild, A., Rutkowski, P., Testori, A., Levchenko, E., Enk, A., Misery, L., Vanden Abeele, C., Vojtek, I., Peeters, O., Brichard, V. G., Therasse, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035794/
https://www.ncbi.nlm.nih.gov/pubmed/27502712
http://dx.doi.org/10.1093/annonc/mdw291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035794/
https://www.ncbi.nlm.nih.gov/pubmed/27502712
http://dx.doi.org/10.1093/annonc/mdw291

Ejemplares similares